Virtu Financial »

Xilio Therapeutics shares owned by Virtu Financial

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Virtu Financial from 13F filings

Historical chart of Virtu Financial investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Virtu Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Virtu Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.0k 11k 0.56

More positions owned by Virtu Financial

Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Select Sector Spdr Tr Technology (XLK)
Meta Platforms Cl A (META)
Direxion Shs Etf Tr Drx S P500bull (SPXL)
Direxion Shs Etf Tr 20yr Tres Bear (TMV)
Vanguard Index Fds S P 500 Etf Shs (VOO)
Select Sector Spdr Tr Financial (XLF)
Synopsys (SNPS)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Altria (MO)
Hess (HES)
Pfizer (PFE)
News Corp Cl A (NWSA)
Invesco Currencyshares Cdn D CDN DLR SHS (FXC)

View all positions for Virtu Financial

Top funds holding Xilio Therapeutics

Atlas Venture Life Science Advisors
Octagon Capital Advisors
RiverVest Venture Management
Vanguard Group
Artal Group
Laurion Capital Management
Arrowpoint Asset Management
Citadel Advisors
Millennium Management
PFG Investments
Summit Trail Advisors
Charles Schwab Investment Management
Virtu Financial
Dunhill Financial
Jpmorgan Chase & Co

View all funds holding Xilio Therapeutics